Refile: BRIEF-Sprint Bioscience Q4 Operating Loss Narrows To SEK 10.2 Mln

Sprint Bioscience AB

19/02/2020 06:32

(Refiles to correct word in headline)
    Feb 19 (Reuters) - Sprint Bioscience AB  SPRINT.ST :
    * Q4 NET SALES SEK 5.3 MILLION VERSUS SEK 0.2 MILLION YEAR
AGO
    * PROPOSES NO DIVIDEND FOR 2019
    * Q4 OPERATING LOSS SEK 10.2 MILLION VERSUS LOSS SEK 12.4
MILLION
YEAR AGO

Source text for Eikon:  ID:nWkr69lQbG 
Further company coverage:  SPRINT.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))